GSKH vs. GERM
GSKH (GSK plc ADRhedged ETF) and GERM (Amplify Treatments, Testing and Advancements ETF) are both Health & Biotech Equities funds - GSKH tracks the GSK plc Local Shares Total Return while GERM tracks the Prime Treatments, Testing and Advancements Index. Both are passively managed. Over the past year, GSKH returned 30.78% vs 0.00% for GERM. GSKH charges 0.19%/yr vs 0.68%/yr for GERM.
Performance
GSKH vs. GERM - Performance Comparison
Loading charts...
Returns By Period
GSKH
- 1D
- 1.34%
- 1M
- 4.57%
- YTD
- 7.84%
- 6M
- 8.19%
- 1Y
- 30.78%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
GERM
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- 0.00%
- 6M
- 0.00%
- 1Y
- 0.00%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
GSKH vs. GERM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
GSKH GSK plc ADRhedged ETF | 7.84% | 37.05% |
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% |
GSKH vs. GERM - Sectors Allocation Comparison
Sectors
GSKH
GERM
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
GSKH
GERM
Basic Materials
GSKH
-
GERM
-
Communication Services
GSKH
-
GERM
-
Consumer Cyclical
GSKH
-
GERM
-
Consumer Defensive
GSKH
-
GERM
-
Energy
GSKH
-
GERM
-
Financial Services
GSKH
-
GERM
Industrials
GSKH
-
GERM
-
Real Estate
GSKH
-
GERM
-
Technology
GSKH
-
GERM
-
Utilities
GSKH
-
GERM
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GSKH vs. GERM — Risk / Return Rank
GSKH
GERM
GSKH vs. GERM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for GSK plc ADRhedged ETF (GSKH) and Amplify Treatments, Testing and Advancements ETF (GERM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| GSKH | GERM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.23 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 1.67 | — | — |
| Martin ratioReturn relative to average drawdown | 4.06 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| GSKH | GERM | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.18 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 1.19 | — | — |
Drawdowns
GSKH vs. GERM - Drawdown Comparison
The maximum GSKH drawdown since its inception was -18.54%, which is greater than GERM's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for GSKH and GERM.
Loading charts...
Drawdown Indicators
| GSKH | GERM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -18.54% | 0.00% | -18.54% |
Max Drawdown (1Y)Largest decline over 1 year | -18.54% | 0.00% | -18.54% |
Current DrawdownCurrent decline from peak | -13.28% | 0.00% | -13.28% |
Average DrawdownAverage peak-to-trough decline | -5.65% | 0.00% | -5.65% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.61% | 0.00% | +7.61% |
Volatility
GSKH vs. GERM - Volatility Comparison
GSK plc ADRhedged ETF (GSKH) has a higher volatility of 6.33% compared to Amplify Treatments, Testing and Advancements ETF (GERM) at 0.00%. This indicates that GSKH's price experiences larger fluctuations and is considered to be riskier than GERM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GSKH | GERM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.33% | 0.00% | +6.33% |
Volatility (6M)Calculated over the trailing 6-month period | 18.35% | 0.00% | +18.35% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.30% | 0.00% | +26.30% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 27.08% | 0.00% | +27.08% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.08% | 0.00% | +27.08% |
GSKH vs. GERM - Expense Ratio Comparison
GSKH has a 0.19% expense ratio, which is lower than GERM's 0.68% expense ratio.
Dividends
GSKH vs. GERM - Dividend Comparison
GSKH's dividend yield for the trailing twelve months is around 1.57%, while GERM has not paid dividends to shareholders.
| Position | TTM | 2025 |
|---|---|---|
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% |
GSKH GSK plc ADRhedged ETF | 1.57% | 1.15% |
Frequently Asked Questions
GSKH has higher volatility (6.33%) compared to GERM (0.00%). In terms of maximum drawdown, GSKH dropped -18.54% vs GERM's 0.00%.
On 1-year performance, GSKH leads with 30.78% vs 0.00% for GERM. On fees, GSKH is cheaper at 0.19% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, GSKH has performed better with a 30.78% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
GSKH is cheaper with a 0.19% expense ratio, compared with 0.68% for GERM.
GSKH has the higher dividend yield at 1.57%, compared with 0.00% for GERM.
GSKH tracks GSK plc Local Shares Total Return, while GERM tracks Prime Treatments, Testing and Advancements Index. They also come from different issuers: ADRhedged and Amplify. Their fees differ too: 0.19% for GSKH and 0.68% for GERM.
Find the right allocation for GSKH and GERM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer